trial_title,drug_name,moa,innovation_generic_biosimilar,category
"Random, single oral administration, double cycle, double cross, bioequivalence test of Cinacalcet Hydrochloride Tablets in healthy subjects under fasting and postprandial state",cinacalcet hydrochloride,"Receptors, Calcium-Sensing",Generic,cytokine_hormone_receptor_modulators
Study of Xenopax for the treatment of rejection in kidney transplant.,Xenopax,Interleukin-2 Receptor alpha Subunit,Biosimilar,cytokine_hormone_receptor_modulators
"A single intravenous administration of recombinant erythropoiesis-stimulating protein injection (CHO cells) to explore the tolerability, safety and pharmacokinetic characteristics of healthy subjects",recombinant erythropoiesis-stimulating protein,"Receptors, Erythropoietin",Innovative,cytokine_hormone_receptor_modulators
A Pivotal Study of SB8 Anti-VEGF Antibody in Patients with Metastatic Colon Cancer and Non-Small Cell Lung Cancer.,SB8,Vascular Endothelial Growth Factor A,Biosimilar,targeted_pathway_inhibitors
A Mass Balance Study of [14C]SSS17 in Healthy Chinese Male Subjects,SSS-17,Prolyl-Hydroxylase Inhibitors,Innovative,metabolic_pathway_modulators
"A randomized, open label, crossover, bioequivalence, bioavailability, safety study of metformin hydrochloride sustained-release tablets in healthy volunteers under fasting and postprandial administration",Metformin hydrochloride sustained-release tablets,Gluconeogenesis,Generic,metabolic_pathway_modulators
A Phase III study of RD001 for the treatment of Anemia,RD-01,"Receptors, Erythropoietin",Innovative,cytokine_hormone_receptor_modulators
"A Single-center, Single-arm, Open-label, Single-dose Phase I Clinical Study to Evaluate Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of rhTPO in Healthy Caucasian Participants. Approximately 22 Subjects Will be Enrolled.",Recombinant human thrombopoietin,"Receptors, Thrombopoietin",Innovative,cytokine_hormone_receptor_modulators
A Phase II Study to Evaluate the Safety and Efficacy of SSGJ-705 Monotherapy and Combination Therapy in Patients With Advanced HER2-Expressing Solid Tumors,SSGJ-705,"Antibodies, Bispecific",Innovative,biologic_antibodies_biologics
A Phase III Pivotal Trial to Evaluate 602 in Patients with Colorectal Cancer,602,ErbB Receptors,Innovative,supportive_adjunctive_agents
A phase II/III clinical trial of 601A in Age-Related Macular Degeneration.,601A,Vascular Endothelial Growth Factor A,Innovative,targeted_pathway_inhibitors
"A Phase I, Multicenter, Open-Label, First-in-Human Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Potential Anti-tumor Effects of SSGJ-705 in Patients With Advanced or Metastatic HER2-expressing Solid Tumors",SSGJ-705,"Antibodies, Bispecific",Innovative,biologic_antibodies_biologics
"A Multicenter, Randomized, Double-blind, Placebo-controlled Phase II, Efficacy and Safety Study of Recombinant Anti-IL-5 Humanized Monoclonal Antibody Therapy in Adult Subjects With Severe Eosinophilic Asthma",SSGJ-610,Interleukin-5,Innovative,supportive_adjunctive_agents
"A Multicenter, Single-Arm, Open Label Study Evaluating the Efficacy and Safety of Maintenance Treatment With Recombinant Human Thrombopoietin in Thrombocytopenic Subjects With Immune Thrombocytopenia",recombinant human thrombopoietin,"Receptors, Thrombopoietin",Innovative,cytokine_hormone_receptor_modulators
"A Multicenter, Randomized, Double-blind, Placebo-controlled Phase IIb, Effcacy and Safety Study of Recombinant Anti-IL-5 Humanized Monoclonal Antibody Therapy in Adult Subjects With Severe Asthma",SSGJ-610,Interleukin-5,Innovative,supportive_adjunctive_agents
A Phase II Study of SSGJ-707 Monotherapy in First-line PD-L1 Positive Advanced NSCLC Patients,SSGJ-707,Programmed Cell Death 1 Receptor,Innovative,immune_checkpoint_immune_modulation
"Study on the tolerability, pharmacokinetics and pharmacodynamics of a single subcutaneous injection of recombinant human thrombopoietic factor injection (rh-TPO) in healthy adults",Recombinant human thrombopoietin,"Receptors, Thrombopoietin",Biosimilar,cytokine_hormone_receptor_modulators
"rESP Medication With a  to Explore the Tolerability ,Safety and Pharmacokinetic Characteristics for Healthy Subjects in the Phase I Clinical Study",Recombinant erythropoietin stimulating protein,"Receptors, Erythropoietin",Innovative,cytokine_hormone_receptor_modulators
A Phase IV study of Yisaipu for rheumatoid arthritis,Yisaipu,Tumor Necrosis Factor Inhibitors,Biosimilar,metabolic_pathway_modulators
Effect of Food on the Pharmacokinetics of SSS17 Capsules: A Study in Chinese Healthy Subjects,SSS-17,Prolyl-Hydroxylase Inhibitors,Innovative,metabolic_pathway_modulators
"A Randomized, Double Blind, Placebo Controlled Trial with Humanized TNFalpha Monoclonal Antibody Injection by Single Dose and Dose Escalation to Explore the Tolerance, Safety and Pharmacokinetic Characteristics in Healthy Subjects",SSS-07,Tumor Necrosis Factor-alpha,Innovative,immune_checkpoint_immune_modulation
"A Randomized, Double-blind, Placebo-controlled Phase I Clinical Trial Evaluating the Safety, Tolerability, and Pharmacokinetics of SSS39 Injection by Single Intravenous Infusion in Healthy Chinese Subjects",SSS39,MTOR Inhibitors,Innovative,targeted_pathway_inhibitors
A Phase II Study of SSGJ-707 Combination Therapy in Advanced NSCLC Patients,SSGJ-707,Programmed Cell Death 1 Receptor,Innovative,immune_checkpoint_immune_modulation
A Clinical Study of SSGJ-613 combined with SSGJ-707±chemotherapy in the treatment of advanced non-small cell lung cancer,SSGJ-707+SSGJ-613,Programmed Cell Death 1 Receptor+Interleukin-1beta,Innovative+Innovative,immune_checkpoint_immune_modulation+supportive_adjunctive_agents
"A Phase III, Randomized, Multicentre, Open-Label, Concentration-Controlled, Safety and Efficacy Study of Voclosporin and Tacrolimus in Renal Transplantation",voclosporin,Calcineurin Inhibitors,Innovative,small_molecule_immunomod_antiinflammatory
A Phase I study on the effect of RD001 for the treatment of Anemia,RD001,"Receptors, Erythropoietin",Innovative,cytokine_hormone_receptor_modulators
"A Multicenter, Randomized, Double-blind, Double Dummy, placebo and Positive Controlled, phase II Clinical Study to Evaluate the Efficacy and Safety of 608 in Patients with Ankylosing Spondylitis (AS)",SSGJ-608,Interleukin-17,Innovative,supportive_adjunctive_agents
A Clinical Study of SSGJ-706 Injection in Patients with relapsed/refractory lymphoma.,SSGJ-706,Immune Checkpoint Inhibitors,Innovative,immune_checkpoint_immune_modulation
A Phase II Study to Evaluate the Safety and Efficacy of SSGJ-707 in Advanced Gynecologic Cancer Patients,SSGJ-707,Programmed Cell Death 1 Receptor,Innovative,immune_checkpoint_immune_modulation
"A Proof of Principle, Phase II Trial of Uricase-PEG 20 in Patients with Resistant/Refractory Gout",pegadricase,Urate Oxidase,Innovative,supportive_adjunctive_agents
"Randomization, double-blind, placebo study on the safety, tolerability and PK characteristics of single administration of recombinant anti-IL-5 humanized monoclonal antibody injection in healthy people",SSGJ-610,Interleukin-5,Innovative,supportive_adjunctive_agents
A Single-center Phase I Clinical Study Evaluating the Pharmacokinetics and Safety of Single and Multiple Oral Administration of Narfurine Hydrochloride Orally Disintegrating Tablets in Chinese Healthy Adult Subjects,narfurine hydrochloride,"Receptors, Opioid, kappa",Innovative,supportive_adjunctive_agents
A Phase I Study of Apremilast for treating Psoriatic Arthritis.,Apremilast,Phosphodiesterase 4 Inhibitors,Generic,small_molecule_immunomod_antiinflammatory
"A Phase I, multiple dose study on safety and  tolerability of Recombinant erythropoietin stimulating protein injection in patients with anemia of associated with chronic kidney disease",NuPIAO,"Receptors, Erythropoietin",Innovative,cytokine_hormone_receptor_modulators
"A Single-Dose, Dose-Increasing, Randomized, Double-Blind Safety And Tolerance Study Of Pegylated Recombinant Candida Urate Oxidase For Injection In Chinese Healthy Adult Subjects Under Different Pretreatment Conditions",pegadricase,Urate Oxidase,Innovative,supportive_adjunctive_agents
"A randomized, open-label, two-sequence, four-cycle bioequivalence study of trifluridine-tipiram and Lonsurf® in patients with metastatic colorectal cancer",trifluridine + tipiracil hydrochloride,"Antimetabolites, Antineoplastic",Generic,classical_cytotoxic_chemotherapy
"A Single Dose Escalation Study to Investigate the Tolerability, Safety, Pharmacokinetics and Pharmacodynamics of SSS17 in Chinese Healthy Subject",SSS-17,Prolyl-Hydroxylase Inhibitors,Innovative,metabolic_pathway_modulators
"A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase II Clinical Study to Evaluate the Efficacy and Safety of 608 in Patients with Non-radiographic Axial Spondyloarthritis (nr-axSpA)",SSGJ-608,Interleukin-17,Innovative,supportive_adjunctive_agents
"A Phase I Study to Evaluate the Safety, Pharmacokinetics and Anti-tumor Activity of SSGJ-709 in Patients With Advanced Malignant Tumors",SSGJ-709,"Antibodies, Bispecific",Innovative,biologic_antibodies_biologics
A Phase I Study of 602 in Patients With Metastatic Colorectal Cancer,602,ErbB Receptors,Innovative,supportive_adjunctive_agents
A Comparative Pharmacokinetic Study of Recombinant Erythropoiesis-Stimulating Protein Injection in Healthy Male Subjects in China,NuPIAO,"Receptors, Erythropoietin",Biosimilar,cytokine_hormone_receptor_modulators
"A randomized, open, single-dose, double-cycle, double-crossover, pharmacodynamics, bioequivalance study of nadroparin calcium injection in healthy subjects under fastingconditions",nadroparin calcium,Factor Xa Inhibitors,Biosimilar,supportive_adjunctive_agents
"A Randomized, Double Masked, Multicenter, Phase II Study Assessing the Safety and Efficacy of 601 Versus Ranibizumab in Patients With Visual Impairment Due to Macular Edema Secondary to Central Retinal Vein Occlusion (CRVO)",601A,Vascular Endothelial Growth Factor A,Innovative,targeted_pathway_inhibitors
"Multicenter, Randomized, Open, Parallel Controlled Trials Evaluating the Efficacy and Safety of Different Human Thrombopoietin (rhTPO) Regimens in the Treatment of Patients With Primary Immune Thrombocytopenia (ITP)",recombinant human thrombopoietin,"Receptors, Thrombopoietin",Innovative,cytokine_hormone_receptor_modulators
A clinical study to evaluate SA102-CAR-T injection for the treatment for relapsed or refractory multiple myeloma,SA102,"Receptors, Chimeric Antigen",Innovative,biologic_antibodies_biologics
A Phase 3 study of TPIAO in Pediatric Patients with Immune Thrombocytopenia (ITP),Recombinant human thrombopoietin,"Receptors, Thrombopoietin",Innovative,cytokine_hormone_receptor_modulators
"Multicenter Phase I/II Study of Docetaxel, Cisplatin and Fluorouracil Combination Chemotherapy in Patients with Advanced or Recurrent Squamous Cell Carcinoma of the Esophagus",docetaxel+cisplatin+fluorouracil,Tubulin Modulators+Cross-Linking Reagents+Thymidylate Synthase,Generic,classical_cytotoxic_chemotherapy+supportive_adjunctive_agents+metabolic_pathway_modulators
A Phase Ia/Ib Study of VTX-0811 for the Treatment of Solid Tumor,VTX-0811,Immune Checkpoint Inhibitors,Innovative,immune_checkpoint_immune_modulation
"Randomized, open, single-dose, dual-cycle, dual-preparation, double-crossover, fasting and postprandial bioequivalence test of Tofacitinib citrate tablets in healthy subjects",tofacitinib citrate,Janus Kinase Inhibitors,Generic,targeted_pathway_inhibitors
"Study on the tolerability, pharmacokinetics and pharmacodynamics of multiple subcutaneous injections of recombinant human thrombopoietic factor injection in patients with thrombocytopenia caused by chemotherapy",recombinant human thrombopoietin,"Receptors, Thrombopoietin",Biosimilar,cytokine_hormone_receptor_modulators
A Phase I Clinical Study of Recombinant anti-PD-1 Humanized Monoclonal Antibody Injection Combined with Initumab and Capecitabine/Oxaliplatin to Treat HER2-positive Unresectable Locally Advanced or Metastatic Gastric Cancer or Gastroesophageal Junction Adenocarcinoma,609-A,Programmed Cell Death 1 Receptor,Innovative,immune_checkpoint_immune_modulation
"A Phase III Global, Multicenter, Randomized, Concentration-Controlled Comparison Study of Voclosporin for The Prevention of Organ Rejection Following Kidney Transplantation",voclosporin,Calcineurin Inhibitors,Innovative,small_molecule_immunomod_antiinflammatory
"A randomized, double-blind, placebo-controlled, multiple-dose injection of recombinant anti-IL-5 humanized monoclonal antibody (610) in asthmatic subjects with elevated eosinophils to evaluate the safety, tolerability and Pharmacokinetic characteristics and clinical research on preliminary efficacy",SSGJ-610,Interleukin-5,Innovative,supportive_adjunctive_agents
"A Multicenter, Randomized, Open Label, Active Comparator Parallel Controlled Phase 2 Clinical Study on Intravenous Administration of rESP Injection for the Treatment of Anemia in Chronic Renal Failure Patients With Hemodialysis",NuPIAO,"Receptors, Erythropoietin",Innovative,cytokine_hormone_receptor_modulators
"A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Clinical Trial to Evaluate the Efficacy and Safety of 610 in Chinese Adult Subjects With Severe Eosinophilic Asthma",SSGJ-610,Interleukin-5,Innovative,supportive_adjunctive_agents
"A Study of Pharmacokinetics, Efficacy, and Safety of 304 Injection Compared With Rituximab in B Cell Non-Hodgkin's Lymphoma",304R,"Antigens, CD20",Biosimilar,supportive_adjunctive_agents
A Phase Ia Dose-escalation Study to Access the Tolerability，Safety，Pharmacokinetics and Pharmacodynamics of Recombinant Human Thrombopoietin in the Patients With Different Degree of Liver Function Impairment,recombinant human thrombopoietin,"Receptors, Thrombopoietin",Innovative,cytokine_hormone_receptor_modulators
"A Phase I , Multicenter, Open-Label, Single/Multiple Dose- Escalation Study of Recombinant Humanized Anti-VEGF Monoclonal Antibody Injection in Patients With Diabetic Macular Edema(DME)",601A,Vascular Endothelial Growth Factor A,Innovative,targeted_pathway_inhibitors
"A Phase 1 Randomized, Double Blinded, Placebo-Controlled Single Dose Escalation Study to Evaluate the Safety, Tolerability and Pharmacokinetic Characteristics of 611 in Adult Healthy Male and Female Volunteers",SSGJ-611,Interleukin-4 Receptor alpha Subunit,Innovative,supportive_adjunctive_agents
SSGJ-621 in subjects with Chronic obstructive pulmonary disorder,SSGJ-621,Interleukin-33,Innovative,immune_checkpoint_immune_modulation
"A Randomized Controlled, Multi-center Phase III Clinical Trial of SSGJ-707 Versus Pembrolizumab as First-line Treatment for PD-L1-Positive Locally-Advanced or Metastatic Non-Small Cell Lung Cancer",SSGJ-707,Programmed Cell Death 1 Receptor,Innovative,immune_checkpoint_immune_modulation
"Efficacy and safety of recombinant human thrombopoietin for the treatment of chronic primary immune thrombocytopenia in children and adolescents: A multicentre, randomized, double-blind, placebo-controlled phase III trial",recombinant human thrombopoietin,"Receptors, Thrombopoietin",Innovative,cytokine_hormone_receptor_modulators
"A Multi-Centered, Randomized, Double-Blinded, Placebo-Controlled Phase II Clinical Trial, to Evaluate the Efficacy and Safety of 611 in Chinese Adults With Moderate to Severe Chronic Obstructive Pulmonary Disease.",SSGJ-611,Interleukin-4 Receptor alpha Subunit,Innovative,supportive_adjunctive_agents
"A Phase I, randomized, open-label, Multiple dose study to evaluate safety, efficacy, tolerance, and pharmacokinetic behavior of subcutaneous humanized anti-human TNF-alpha monoclonal antibody injection in patients with rheumatoid arthritis.",SSS-07,Tumor Necrosis Factor-alpha,Innovative,immune_checkpoint_immune_modulation
"A Multi-Centered, Randomized, Double-Blinded, Placebo-Controlled Phase III Clinical Trial, to Evaluate the Efficacy and Safety of 611 (Recombinant Humanized Anti-interleukin-4 Receptor Alpha IgG4 Monoclonal Antibody) in Chinese Adults With Moderate to Severe Atopic Dermatitis",SSGJ-611,Interleukin-4 Receptor alpha Subunit,Innovative,supportive_adjunctive_agents
Phase I Clinical Trial of Recombinant Anti-VEGF Human Monoclonal Antibody in the Treatment of Wet Age-related Macular Degeneration,601A,Vascular Endothelial Growth Factor A,Innovative,targeted_pathway_inhibitors
A phase 3 clinical trial of SSS13 for the treatment of Hyperphosphatemia,sevelamer carbonate,Ion Exchange Resins,Generic,supportive_adjunctive_agents
"A Randomized, Double-blinded, Placebo-controlled, Single-dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SSS11 Administered Intravenously in Healthy Volunteers",pegadricase,Urate Oxidase,Innovative,supportive_adjunctive_agents
"A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Efficacy and Safety of Recombinant Anti-IL-17A Humanized Monoclonal Antibody in Chinese Patients with Moderate-to-Severe Plaque Psoriasis",SSGJ-608,Interleukin-17,Innovative,supportive_adjunctive_agents
"A Randomized, Double-blind, Placebo-controlled Phase I Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Characteristics of SSS55 Injection in Healthy Subjects in China",SSS55,Complement C3b,Innovative,supportive_adjunctive_agents
"A Controlled, Open-label, Multicenter clinical trial of comparing the Efficacy of JoAS and AoAS with Etanercept and DMARDs",Etanercept+DMARD,Tumor Necrosis Factor Inhibitors,Generic,metabolic_pathway_modulators
"An Open, Single-Arm, Multi-Center Phase II Clinical Study To Evaluate The Efficacy And Safety Of Recombinant Anti-PD-1 Humanized Monoclonal Antibody Injection (609A) In Patients With Unresectable Or Advanced Undifferentiated Pleomorphic Sarcoma",609A,Programmed Cell Death 1 Receptor,Innovative,immune_checkpoint_immune_modulation
A Phase I/II trial of 601a for Age-Related Macular Degeneration,601A,Vascular Endothelial Growth Factor A,Innovative,targeted_pathway_inhibitors
"A Randomized, Double-blind, Placebo-controlled, Multisite Bridging Clinical Study of Nalfurafine Hydrochloride Orally Disintegrating Tablet in the Treatment of Refractory Pruritus in Hemodialysis Patients",Nalfurafine hydrochloride,"Receptors, Opioid, kappa",Innovative,supportive_adjunctive_agents
"A Multicenter, Randomized, Double-blind, Placebo-controlled Study on the Safety, Efficacy and Pharmacokinetics of TPIAO in Children or Adolescents with Chronic ITP (Phase 2)",Recombinant human thrombopoietin,"Receptors, Thrombopoietin",Innovative,cytokine_hormone_receptor_modulators
"A Phase 1 Study to Evaluate the Tolerance, Safety, Pharmacokinetics and Pharmacodynamics of Oral Administration of SSS17 in Chinese Healthy Adult Subjects With Single and Multiple Dose Escalation and the Effect of Food on the Pharmacokinetics of SSS17",SSS17,Prolyl-Hydroxylase Inhibitors,Innovative,metabolic_pathway_modulators
"Phase IIa clinical trial to evaluate the safety and efficacy of recombinant anti-VEGF humanized monoclonal antibody, 3SBio/Sunshine Guojian Pharmaceutical (Shanghai) Co. (Shanghai CP Guojian) in patients with macular edema caused by branch retinal vein occlusion.",601A,Vascular Endothelial Growth Factor A,Innovative,targeted_pathway_inhibitors
A Phase II clinical trial to evaluate SSGJ-706 injection as a monotherapy or in Combination for the treatment of Advanced digestive system cancers,SSGJ-706,Immune Checkpoint Inhibitors,Innovative,immune_checkpoint_immune_modulation
"A Randomized, Double-blind, Placebo-controlled Parallel Trial of Safety, Tolerability and Pharmacokinetic of Recombinant Anti-IL-1ß Humanized Monoclonal Antibody by Single Subcutaneous Injection in Healthy Subjects",SSGJ-613,Interleukin-1beta,Innovative,supportive_adjunctive_agents
"A Phase I, International, Multi-Center, Open-Label Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of BL0020 as A Single Agent in Patients With Advanced Solid Tumors",BL0020,Topoisomerase I Inhibitors,Innovative,classical_cytotoxic_chemotherapy
"A Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose and Multiple Ascending Dose Phase I Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Immunogenicity of SSGJ-627 in Healthy Adult Subjects",SSGJ-627,Tumor Necrosis Factor Ligand Superfamily Member 15,Innovative,immune_checkpoint_immune_modulation
A Phase II Clinical trial to Evaluate SSGJ-705 in combination with or without Pertuzumab/Chemotherapy in Patients with HER2-expressing Advanced Malignant Solid Tumors.,SSGJ-705,"Antibodies, Bispecific",Innovative,biologic_antibodies_biologics
Pharmacokinetic study of once weekly injection of Yisaipu for rheumatoid arthritis,Yisaipu,Tumor Necrosis Factor Inhibitors,Biosimilar,metabolic_pathway_modulators
"A Multi-Center, Randomized, Double-Blind, Placebo-Ccontrolled Phase Ⅲ Clinical Trail， to Evaluate the Efficacy and Safety of 611 (Recombinant Humanized Anti-interleukin-4 Receptor Alpha IgG4 Monoclonal Antibody) in Chinese Adolescents (12 Years Old≤Age < 18 Years Old) With Moderate to Severe Atopic Dermatitis (AD)",SSGJ-611,Interleukin-4 Receptor alpha Subunit,Innovative,supportive_adjunctive_agents
Recombinant human tumor necrosis factor receptor type II - antibody fusion protein injection bioequivalence tests,Yisaipu,Tumor Necrosis Factor Inhibitors,Biosimilar,metabolic_pathway_modulators
"Randomized, double-blind, placebo-controlled, tolerability, safety and pharmacokinetics of single administration 608 injection in healthy volunteers",SSGJ-608,Interleukin-17,Innovative,supportive_adjunctive_agents
A Phase I Study of Recombinant Anti-Epidermal Growth Factor Receptor (EGFR) Human-mouse Chimeric Monoclonal Antibody Injection in Patients With Metastatic Colorectal Cancer,CPGJ602,ErbB Receptors,Biosimilar,supportive_adjunctive_agents
"A single dose, randomized, open label,  bioequivalence study of Fexofenadine hydrochloride tablets for seasonal allergic rhinitis and chronic idiopathic urticaria in healthy male subjects",Fexofenadine hydrochloride,Histamine H1 Antagonists,Generic,small_molecule_immunomod_antiinflammatory
"A Prospective, Randomized, Double Blind, Parallel Group Study to Establish the Therapeutic Equivalence of EPIAO With the Standard Treatment EPREX in Subjects With Chronic Kidney Disease (CKD) Related Anaemia Not Yet on Dialysis

Correction Phase Study (BEAT_001)",EPIAO,"Receptors, Erythropoietin",Biosimilar,cytokine_hormone_receptor_modulators
"A Phase 3, Multicenter, Randomized, Double-blind, Double-dummy, Active-controlled Trial to Evaluate the Efficacy and Safety of Recombinant Anti-IL-1β Humanized Monoclonal Antibody Injection in Chinese Participants With Acute Gout",SSGJ-613,Interleukin-1beta,Innovative,supportive_adjunctive_agents
A Phase II Study of SSGJ-706 Monotherapy and Combination Therapy in Advanced Non-Small Cell Lung Cancer（NSCLC） Patients,SSGJ-706,Immune Checkpoint Inhibitors,Innovative,immune_checkpoint_immune_modulation
"A Randomized, Open-label, Active-Controlled Phase II Trial to Evaluate the Efficacy and Safety of SSGJ-613 for Prophylaxis Against Acute Gouty Arthritis Flares in Subjects Initiating Urate-Lowering Treatment.",SSGJ-613,Interleukin-1beta,Innovative,supportive_adjunctive_agents
"A Phase Ib/II Study to Evaluate the Safety, Pharmacokinetic and Efficacy of Recombinant Anti-interleukin-4 Receptor Alpha Monoclonal Antibody Injection (611) in Chinese Children and Adolescents (6 Years Old ≤ Age <18 Years Old) With Moderate to Severe Atopic Dermatitis.",SSGJ-611,Interleukin-4 Receptor alpha Subunit,Innovative,supportive_adjunctive_agents
"A Randomized, Open-label, Parallel-enrollment Pharmacokinetic Comparison Study of Two Formulations of Recombinant Anti-IL-4Rα Humanized Monoclonal Antibody Injection (611) Injected Subcutaneously in Healthy Adult Subjects in China",SSGJ-611,Interleukin-4 Receptor alpha Subunit,Innovative,supportive_adjunctive_agents
"Open, Randomized, Comparative, Multicenter Study in Parallel Groups of the Efficacy, Safety, Immunogenicity of Etanercept and Enbrel, Lyophilisates for Solution for Subcutaneous Injection, in Patients With Rheumatoid Arthritis",Yisaipu,Tumor Necrosis Factor Inhibitors,Biosimilar,metabolic_pathway_modulators
"Safety, Tolerability, Pharmacokinetics, and Preliminary Pharmacological Studies of SSS11 in Patients With Gout and Hyperuricemia After Multiple Administrations, Dose Escalation, Randomized Double-blind, Placebo-controlled Trials",pegadricase,Urate Oxidase,Innovative,supportive_adjunctive_agents
"Phase I Clinical Study on the Safety, Pharmacokinetics and Antitumor Activity of SSGJ-612 in Patients With Advanced Solid Tumors",SSGJ-612,"Receptor, ErbB-2",Innovative,targeted_pathway_inhibitors
A Phase II Clinical Trial of Bcl-2/xL Inhibitor In Patients With Non-Small Cell Lung Cancer,TM-1251,Proto-Oncogene Proteins c-bcl-2,Innovative,supportive_adjunctive_agents
"A First-in-Human, Open-label, Phase 1 Dose-Escalation Study of 609A in Subjects With Locally Advanced / Metastatic Solid Tumors",609A,Programmed Cell Death 1 Receptor,Innovative,immune_checkpoint_immune_modulation
"Safety and Efficacy of Prefilled Liquid Etanercept(Yisaipu) for Active Ankylosing Spondylitis on the Basis of NSAID Therapy: A Multicenter Randomized, Double-blind, Parallel Group Phase III Trial",Etanercept,Tumor Necrosis Factor Inhibitors,Biosimilar,metabolic_pathway_modulators
"A Clinical Study of Recombinant Anti-EGFR Human Mouse Chimeric Monoclonal Antibody Injection in Patients with HER2-positive Metastatic Colorectal Cancer with Wild-type KRAS, NRAS, and BRAF",3SB602,ErbB Receptors,Innovative,supportive_adjunctive_agents
"A single-center, open, random, single-dose, two-period, two-sequence of healthy adult subjects in the fasting and post-meal state, Cross bioequivalence study of Apremilast tablets and the reference preparation OTEZLA",apremilast,Phosphodiesterase 4 Inhibitors,Generic,small_molecule_immunomod_antiinflammatory
"A Randomized, Open-Label, Active-Controlled, Multicenter Phase II/III Clinical Study to Evaluate the Safety and Efficacy of SSS06 in the Treatment of Chemotherapy-Induced Anemia in Patients with Non-Myeloid Malignancies",SSS06,"Receptors, Erythropoietin",Innovative,cytokine_hormone_receptor_modulators
"A Phase 1, bioequivalence, random, open, two preparations, single oral administration, double cycles, double crossing study of fexofenadine hydrochloride tablets (60 mg) before and after meals in healthy adults",Fexofenadine hydrochloride,Histamine H1 Antagonists,Generic,small_molecule_immunomod_antiinflammatory
"A Phase I Clinical Study of the Safety, Pharmacokinetics, and Antitumor Activity of SSS59 in Patients With Advanced Malignant Tumors",SSS59,"Antibodies, Bispecific",Innovative,biologic_antibodies_biologics
"Optimizing Psoriasis Treatment of Etanercept Combined Methotrexate: a Phase IV, Multicenter, Randomized, Double-blind, Controlled Trial",Etanercept+Methotrexate,Tumor Necrosis Factor Inhibitors+Folic Acid Antagonists,Generic,metabolic_pathway_modulators
A phase 1 study to evaluate the SSS55 injection for the treatment of IgA nephropathy and membranous nephropathy,SSS-55,Complement C3b,Innovative,supportive_adjunctive_agents
"A mutiple -dose, dose-escalation phase I study on the tolerability and safety of recombinant erythropoiesis stimulating protein ( CHO cell ) injection in patients with chronic kidney disease with anemia",NuPIAO,"Receptors, Erythropoietin",Innovative,cytokine_hormone_receptor_modulators
"Recombinant Anti-EGFR Human Mouse Chimeric Monoclonal Antibody Injection And Erbitux Pharmacokinetic Properties, Immunogenicity And Safety Comparison In Healthy Male Volunteers",CPGJ602,ErbB Receptors,Biosimilar,supportive_adjunctive_agents
A phase II study of Nuleusin (rhIL-2) in patients with metastatic renal carcinoma.,Nuleusin,"Receptors, Interleukin-2",Biosimilar,cytokine_hormone_receptor_modulators
A Multicenter Phase Ib Clinical Study for Recombinant Human Thrombopoietin Injection in the Treatment of Thrombocytopenia in Patients With Chronic Liver Disease,Recombinant human thrombopoietin,"Receptors, Thrombopoietin",Innovative,cytokine_hormone_receptor_modulators
"A single-arm, multi-center phase II clinical study evaluating the efficacy and safety of inituzumab combined with pertuzumab and nab-paclitaxel in neoadjuvant therapy for HER2-positive breast cancer",Inetetamab,"Receptor, ErbB-2",Innovative,targeted_pathway_inhibitors
"A First-in-Human, Open-label, Phase I Dose-Escalation Study of 609A in Subjects With Locally Advanced/Metastatic Solid Tumors in China",609A,Programmed Cell Death 1 Receptor,Innovative,immune_checkpoint_immune_modulation
A Phase III Randomized Study for HER2-Overexpressed Metastatic Breast Cancer Patients Treated by Trastuzumab (Cipterbin) Plus vinorelbinE Simultaneously or Sequencely.,inetetamab,"Receptor, ErbB-2",Biosimilar,targeted_pathway_inhibitors
A Phase I Clinical Study of SSGJ-617 injection Intended for the Treatment of Patients with Advanced Solid Tumor,SSGJ-617,Immune Checkpoint Inhibitors,Innovative,immune_checkpoint_immune_modulation
A Phase I Study Of  Recombinant Anti-PD-1 Humanized Monoclonal Antibody Injection with Bevacizumab Assisted Transarterial Chemoembolization (TACE) for the Treatment of Hepatocellular Carcinoma Patients Who are Not Suitable for Radical Treatment,609-A+bevacizumab,Programmed Cell Death 1 Receptor+Vascular Endothelial Growth Factor A,Innovative+Innovative,immune_checkpoint_immune_modulation+targeted_pathway_inhibitors
"Efficacy and safety of infliximab in Chinese patients with rheumatoid arthritis: a double-blind, randomized, placebo-controlled trial.",Infliximab,Tumor Necrosis Factor-alpha,Innovative,immune_checkpoint_immune_modulation
"A Prospective, Randomized, Double Blind, Parallel Group Study to Evaluate a 1:1 Dose Conversion From EPREX to EPIAO in Term of Clinical Efficacy and Safety in Subjects With End-Stage Renal Disease on Haemodialysis",EPIAO,"Receptors, Erythropoietin",Biosimilar,cytokine_hormone_receptor_modulators
A Phase III Study of Voclosporin for the Treatment of Autoimmune Diseases,voclosporin,Calcineurin Inhibitors,Innovative,small_molecule_immunomod_antiinflammatory
"An Open-label, Multicenter, Dose-escalation and Dose-expansion Phase I Clinical Study Evaluating the Safety, Tolerability, Pharmacokinetics and Antitumor Activity of SSGJ-707 in Patients with Advanced or Metastatic Solid Tumors",SSGJ-707,Programmed Cell Death 1 Receptor,Innovative,immune_checkpoint_immune_modulation
"An Open-labeled, Multi-center, Randomized, Prospective Phase III Study Comparing CMAB304 in Combination with CHOP to CHOP Alone with CMAB304 Maintenance in Patients with DLBCL",CMAB304,"Antigens, CD20",Biosimilar,supportive_adjunctive_agents
"A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase III Clinical Study to Evaluate the Efficacy and Safety of 611 in Patients with Chronic Rhinosinusitis with Nasal Polyps (CRSwNP)",SSGJ-611,Interleukin-4 Receptor alpha Subunit,Innovative,supportive_adjunctive_agents
A Clinical Study of Recombinant anti-BDCA2 humanized monoclonal antibody injection for treatment of Systemic lupus erythematosus (SLE),anti-BDCA2 humanized monoclonal antibody,"Antibodies, Monoclonal, Humanized",Innovative,biologic_antibodies_biologics
"A Study of Pegsiticase in pediatric oncology patients with, or at risk for, tumor lysis syndrome",pegadricase,Urate Oxidase,Innovative,supportive_adjunctive_agents
"A Randomized, Multi-center, Open label trial to establish the therapeutic equivalence between Epiao and Eprex and to determine the long term safety profile of Epiao in patients on Hemodialysis",Epiao,"Receptors, Erythropoietin",Biosimilar,cytokine_hormone_receptor_modulators
A Phase I Trial of Inetetamab for injection in Patients with HER2-Positive Early Breast Cancer,inetetamab,"Receptor, ErbB-2",Biosimilar,targeted_pathway_inhibitors
"A Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose Phase I Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Immunogenicity of SSGJ-626 in Healthy Adult Subjects",SSGJ-626,"Lectins, C-Type",Innovative,immune_checkpoint_immune_modulation
"Phase Ib/IIa Clinical Trial to Evaluate the Safety, Efficacy, and Pharmacokinetic Characteristics of SSS40 in Subjects With Moderate to Severe Bone Metastasis Cancer Pain",SSS-40,Nerve Growth Factor,Innovative,supportive_adjunctive_agents
"A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase Ib/II Study to Evaluate the Safety, Efficacy, Pharmacokinetics, and Immunogenicity of Anti-BDCA2 Antibody SSGJ-626 in Subjects With Systemic Lupus Erythematosus",SSGJ-626,"Lectins, C-Type",Innovative,immune_checkpoint_immune_modulation
"A Phase Ib/II Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of Recombinant Anti-IL-1β Humanized Monoclonal Antibody Injection in Chinese Participants With Acute Gout",SSGJ-613,Interleukin-1beta,Innovative,supportive_adjunctive_agents
"A single dose, dose-escalation phase I study on the tolerability and safety of recombinant erythropoiesis stimulating protein (CHO cell) injection in healthy subjects",NuPIAO,"Receptors, Erythropoietin",Innovative,cytokine_hormone_receptor_modulators
"A Randomized, Double Masked, Multicenter, Phase III Study Assessing the Efficacy and Safety of 601 Versus Ranibizumab in Patients With Macular Edema Secondary to Branch Retinal Vein Occlusion (BRVO)",601A,Vascular Endothelial Growth Factor A,Innovative,targeted_pathway_inhibitors
Pharmacokinetic study of twice weekly injection of Yisaipu for rheumatoid arthritis,Yisaipu,Tumor Necrosis Factor Inhibitors,Biosimilar,metabolic_pathway_modulators
"A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase IIa Trial to Evaluate the Efficacy and Safety of Oral SSS17 Capsules in the Treatment of Anemia Following Total Hip or Knee Arthroplasty",SSS17,Prolyl-Hydroxylase Inhibitors,Innovative,metabolic_pathway_modulators
"A Phase I Clinical Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of SSGJ-705 Monotherapy in Patients With Advanced Malignant Tumors",SSGJ-705,"Antibodies, Bispecific",Innovative,biologic_antibodies_biologics
"A Multicenter, Randomized, Parallel-controlled Phase III Trial Comparing the Efficacy and Safety of Recombinant Erythropoiesis Stimulating Protein Injection (CHO Cell) With Ipbio in Maintenance Therapy in Hemodialysis Patients With Anemia in Chronic Renal Failure",NuPIAO,"Receptors, Erythropoietin",Innovative,cytokine_hormone_receptor_modulators
A Phase II trial of a humanized anti-TNF alpha antibody (SSS07) in patients with RA and other inflammatory diseases.,SSS07,Tumor Necrosis Factor-alpha,Innovative,immune_checkpoint_immune_modulation
"Evaluate the effect of Eltrombopag Ethanolamine Tablets and Reflex on Healthy Adult Subjects Under Fasting Conditions: single center, open, random, single dose, two cycles, two sequences, cross biological Equivalence study",Eltrombopag olamine,"Receptors, Thrombopoietin",Generic,cytokine_hormone_receptor_modulators
Clinical Study of 18F-FDG PET/CT in Predicting and Guiding Neoadjuvant Therapy for HER2-Positive Early or Locally Advanced Breast Cancer,docetaxel+cisplatin+cyclophosphamide+ifosfamide+paclitaxel,"Tubulin Modulators+Cross-Linking Reagents+Antineoplastic Agents, Alkylating+Antineoplastic Agents, Alkylating+Tubulin Modulators",Generic,classical_cytotoxic_chemotherapy+supportive_adjunctive_agents
"A single subcutaneous injection dose, dose-escalation phase I study on the tolerability and safety of recombinant erythropoiesis stimulating proteininjection (CHO cell) in patients with chronic kidney disease with anaemia",NuPIAO,"Receptors, Erythropoietin",Innovative,cytokine_hormone_receptor_modulators
An Open-Label Randomized Phase II Study of Cipterbin or Cipterbin in Combination With Vinorelbine in Patients With HER2/Neu-overexpressed Metastatic Breast Cancer (MBC),inetetamab,"Receptor, ErbB-2",Biosimilar,targeted_pathway_inhibitors
"Phase I Clinical Study to Evaluate the Safety, Tolerability, and Initial Efficacy of SSGJ-706 Monotherapy for Patients With Advanced Solid Tumors",SSGJ-706,Immune Checkpoint Inhibitors,Innovative,immune_checkpoint_immune_modulation
"An Open Label, Single-dose, Dose-increasing Study to Assess the Safety, Tolerability, PK and Preliminary PD of PEGylated Recombinant Candida Urate Oxidase (SSS11) for Injection in Chinese Healthy Adult Volunteers",pegadricase,Urate Oxidase,Innovative,supportive_adjunctive_agents
"A single-center, randomized, double-blind, placebo-controlled Phase I clinical study of the safety, tolerability, pharmacokinetics, and immunogenicity of SSS40 in healthy Chinese subjects with a single dose and escalating doses",SSS40,Nerve Growth Factor,Innovative,supportive_adjunctive_agents
A study of the human bioequivalence of eltrombopag ethanolamine tablets,eltrombopag olamine,"Receptors, Thrombopoietin",Generic,cytokine_hormone_receptor_modulators
Comparing the Efficacy and Safety of Optimized rhTPO Treatment Versus Eltrombopag Treatment in Previously Treated Primary Immune Thrombocytopenia Patients: A Multicenter Randomized Open-label Trial,recombinant human thrombopoietin,"Receptors, Thrombopoietin",Innovative,cytokine_hormone_receptor_modulators
A Phase I Study of SSS24 in Patients With Colorectal Cancer,SSS-24,,Innovative,
"A Multi-Centered, Randomized, Double-Blinded, Placebo-Controlled Phase Ⅲ Clinical Trial to Evaluate the Efficacy and Safety of 611(Recombinant Humanized Anti-interleukin-4 Receptor Alpha IgG4 Monoclonal Antibody) When Used In Combination With Topical Corticosteroid Treatment (TCS) in Participants With Moderate to Severe Atopic Dermatitis.",SSGJ-611,Interleukin-4 Receptor alpha Subunit,Innovative,supportive_adjunctive_agents
"A Randomized, Double-blind, Placebo-controlled, Multiple Dose Escalation Phase I Clinical Study of Humanized Monoclonal Antibody Injection (SSGJ-613) in Healthy Adult Chinese Subjects",SSGJ-613,Interleukin-1beta,Innovative,supportive_adjunctive_agents
"To Evaluate PD-1 Monoclonal Antibody In Combination With Inituzumab, Pertuzumab, Chemotherapy And Inituzumab In Combination With Pertuzumab, Chemotherapy Compared With Trastuzumab Plus Pertuzumab, Chemotherapy A Randomized, Open-Label, Parallel-Controlled Phase II Clinical Study Of The Efficacy And Safety Of Chemotherapy Neoadjuvant Therapy In Patients With Early-Stage HER2-Positive Breast Cancer",609-A,Programmed Cell Death 1 Receptor,Innovative,immune_checkpoint_immune_modulation
"A Multi-Centered, Randomized, Double-Blinded, Placebo-Controlled Phase II Clinical Trial, to Evaluate the Efficacy and Safety of 611 in Chinese Adults With Moderate to Severe Atopic Dermatitis.",SSGJ-611,Interleukin-4 Receptor alpha Subunit,Innovative,supportive_adjunctive_agents
"A Multi-Centered, Randomized, Double-Blinded, Placebo-Controlled Phase III Clinical Trial, to Evaluate the Efficacy and Safety of 611 in Chinese Adults With Moderate to Severe Chronic Obstructive Pulmonary Disease",SSGJ-611,Interleukin-4 Receptor alpha Subunit,Innovative,supportive_adjunctive_agents
"A Phase I Study to Evaluate the Safety, Tolerability, and Initial Efficacy of HBT-708 Monotherapy for Patients With Advanced Solid Tumors",HBT-708,Programmed Cell Death 1 Receptor,Innovative,immune_checkpoint_immune_modulation
"A Multicenter, Randomized, Single-blind, Active Comparator Controlled Phase 2 Clinical Study on the Effectiveness, Safety and Pharmacokinetics of PEGylated recombinant human erythropoietin injection (RD01) in Different Medication Schemes for the Treatment of Anemia in Chronic Renal Failure Patients With Hemodialysis",RD01,"Receptors, Erythropoietin",Innovative,cytokine_hormone_receptor_modulators
A randomized control trial of prophylactic application of recombinant human thrombopoietin (rhTPO) for thrombocytopenia caused by high-dosed chemotherapy,recombinant human thrombopoietin,"Receptors, Thrombopoietin",Innovative,cytokine_hormone_receptor_modulators
A Phase II Study to Evaluate the Safety and Efficacy of SSGJ-707 As First-Line Treatment in Metastatic Colorectal Cancer Patients,SSGJ-707,Programmed Cell Death 1 Receptor,Innovative,immune_checkpoint_immune_modulation
A study of undisclosed monoclonal antibody for psoriasis treatment.,Undisclosed monoclonal antibody,"Antibodies, Monoclonal",Innovative,biologic_antibodies_biologics
"A Multicenter, Randomized, Double-blind, Placebo-controlled Study on the Safety, Efficacy and Pharmacokinetics of TPIAO in Children or Adolescents with Chronic ITP (Phase 1)",Recombinant human thrombopoietin,"Receptors, Thrombopoietin",Innovative,cytokine_hormone_receptor_modulators
"A Phase I Study To Evaluate The Safety, Tolerability, Pharmacokinetic Characteristics And Preliminary Effectiveness Of A Humanized Anti-HER2 Monoclonal Antibody For Injection (SSGJ-612 For Injection) As A Single Agent In The Treatment Of HER2-Positive Advanced Solid Tumors",SSGJ-612,"Receptor, ErbB-2",Innovative,targeted_pathway_inhibitors
"A multicenter, randomized, double-blind, placebo-controlled phase II clinical study evaluating the efficacy and safety of 611 in subjects with chronic rhinosinusitis with nasal polyps (CRSwNP)",SSGJ-611,Interleukin-4 Receptor alpha Subunit,Innovative,supportive_adjunctive_agents
A Clinical Study of SSGJ-709 for injection For Treatment of Patients with Cancer,SSGJ-709,"Antibodies, Bispecific",Innovative,biologic_antibodies_biologics
"A Multicenter,Randomized,Phase 3 Trial to Evaluate the Efficacy and Safety of Recombinant Anti-IL-17A Humanized Monoclonal Antibody in Chinese Patients With Moderate-to-Severe Plaque Psoriasis",SSGJ-608,Interleukin-17,Innovative,supportive_adjunctive_agents
A Phase II Dose-Finding Study to Evaluate the Efficacy and Safety of Oral SSS17 Capsules for Anemia in Non-Dialysis Chronic Kidney Disease Patients,SSS-17,Prolyl-Hydroxylase Inhibitors,Innovative,metabolic_pathway_modulators
A Phase II clinical trial of recombinant anti-IL-17A humanized monoclonal antibody injection subcutaneously in the treatment of patients with moderate to severe plaque psoriasis in China,SSGJ-608,Interleukin-17,Innovative,supportive_adjunctive_agents
Human Bioequivalence Study of Eltrombopag Ethanolamine Tablets,Eltrombopag olamine,"Receptors, Thrombopoietin",Generic,cytokine_hormone_receptor_modulators
"The efficacy and safety of neoadjuvant Inetetamab, Pertuzumab, Toripalimab and Paclitaxel in Patients With Her2-Positive Breast Cancer (A Single-Center Clinical Trial)",pertuzumab+inetetamab+toripalimab+nab-paclitaxel,"Receptor, ErbB-2+Receptor, ErbB-2+Programmed Cell Death 1 Receptor+Tubulin Modulators",Generic,targeted_pathway_inhibitors+immune_checkpoint_immune_modulation+classical_cytotoxic_chemotherapy
A Clinical Trial of a Tumor Vaccine.,Tumor vaccine,Cancer Vaccines,Innovative,vaccines_immune_biologics
A Phase II study on the effect of RD001 for the treatment of Anemia in anemic patients,RD001,"Receptors, Erythropoietin",Innovative,cytokine_hormone_receptor_modulators
Phase II study of recombinant human interleukin-1 receptor antagonist (IL-1ra) for injection,Interleukin-1 receptor antagonist,Interleukin 1 Receptor Antagonist Protein,Biosimilar,immune_checkpoint_immune_modulation
"A multi-center, randomized and parallel control study of EPIAO on cancer-related anemia.",epoetin alfa,"Receptors, Erythropoietin",Biosimilar,cytokine_hormone_receptor_modulators
"A Phase I Clinical Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of SPGL008 Monotherapy for Patients With Advanced Malignant Tumors",SPGL008,Recombinant Fusion Proteins,Innovative,vaccines_immune_biologics
"A Phase I Study Of PEG-Irinotecan in Patients With Metastatic Colorectal Cancer, Metastatic Breast Cancer And Platinum-Resistant Ovarian Cancer",PEG-irinotecan,Topoisomerase I Inhibitors,Innovative,classical_cytotoxic_chemotherapy
Phase Ib/II Study Of CPGJ602 Combined With Initumab And Chemotherapy In The Treatment Of Metastatic Colorectal Cancer,CPGJ602+inetetamab,"ErbB Receptors+Receptor, ErbB-2",Biosimilar+Biosimilar,supportive_adjunctive_agents+targeted_pathway_inhibitors
"A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase II Clinical Study to Evaluate the Efficacy and Safety of 611 in Patients With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)",SSGJ-611,Interleukin-4 Receptor alpha Subunit,Innovative,supportive_adjunctive_agents
"A dose escalation, tolerability, safety and pharmacokinetic study of single administration of  Pegylated recombinant human erythropoietin injection in Chinese healthy subjects",PEGylated recombinant human erythropoietin,"Receptors, Erythropoietin",Innovative,cytokine_hormone_receptor_modulators
A Phase III study of Nuleusin (rhIL-2) for the treatment of metastatic renal carcinoma and metastatic melanoma.,Nuleusin,"Receptors, Interleukin-2",Biosimilar,cytokine_hormone_receptor_modulators
Efficacy and safety of Etanercept (Recombinant Human Tumor Necrosis Factor-α ReceptorⅡ:IgG Fc Fusion Protein for Injection) in the treatment of knee osteoarthritis,Etanercept,Tumor Necrosis Factor-alpha,Innovative,immune_checkpoint_immune_modulation
"A Randomized, Double-Blind, Placebo-Controlled, Single and Repeated Dose Escalation Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Patients With Moderate-to-Severe Atopic Dermatitis",SSGJ-611,Interleukin-4 Receptor alpha Subunit,Innovative,supportive_adjunctive_agents
"A Single Arm, Open Label,Multi-centers Phase II Study, Aimed to Evaluate the Efficacy and Safety of Recombinant Anti-PD-1 Humanized Monoclonal Antibody Injection (609A) Combined With Doxorubicin Hydrochloride in the Treatment of Metastatic/Unresectable Non-specific Soft Tissue Sarcoma",609A,Programmed Cell Death 1 Receptor,Innovative,immune_checkpoint_immune_modulation
"A Randomized, Double Masked, Multicenter, Phase II Study Assessing the Safety and Efficacy of 601 Versus Ranibizumab in Patients With Visual Impairment Due to Pathological Myopic Choroidal Neovascularization (pmCNV)",601,Vascular Endothelial Growth Factor A,Innovative,targeted_pathway_inhibitors
"Efficacy and safety of recombinant human IL-1 receptor antagonist in Chinese patients with rheumatoid arthritis: A double-blind, randomized, placebo-controlled trial",anakinra,Interleukin 1 Receptor Antagonist Protein,Innovative,immune_checkpoint_immune_modulation
A Phase I/II Study of IMM01 in Patients with HER2-positive solid tumors,inetetamab+timdarpacept,"Receptor, ErbB-2+CD47 Antigen",Biosimilar+Innovative,targeted_pathway_inhibitors+immune_checkpoint_immune_modulation
"A Phase II Study Evaluating the Efficacy and Safety of Combination of CPGJ602 and Chemotherapy as First Line Treatment in KRAS/NRAS/BRAF Wild-type, Metastatic Colorectal Cancer Patients",CPGJ602,ErbB Receptors,Biosimilar,supportive_adjunctive_agents
A Phase I Study of Bevacizumab in Patients With Non-Small Cell Lung Cancer,Bevacizumab,Vascular Endothelial Growth Factor A,Biosimilar,targeted_pathway_inhibitors
